
### [Orphanet:485631](http://www.orpha.net/ORDO/Orphanet_485631)
**Label:** Congenital bile acid synthesis defect

**Subclasses:** [Orphanet:79301](http://www.orpha.net/ORDO/Orphanet_79301) (Congenital bile acid synthesis defect type 1), [Orphanet:79303](http://www.orpha.net/ORDO/Orphanet_79303) (Congenital bile acid synthesis defect type 2), [Orphanet:79302](http://www.orpha.net/ORDO/Orphanet_79302) (Congenital bile acid synthesis defect type 3), [Orphanet:79095](http://www.orpha.net/ORDO/Orphanet_79095) (Congenital bile acid synthesis defect type 4), 

**Corr. equiv. classes:** [Orphanet:79303](http://www.orpha.net/ORDO/Orphanet_79303), [OMIM:235555](http://purl.obolibrary.org/obo/OMIM_235555), [OMIM:607765](http://purl.obolibrary.org/obo/OMIM_607765), [Orphanet:79095](http://www.orpha.net/ORDO/Orphanet_79095), [OMIM:613812](http://purl.obolibrary.org/obo/OMIM_613812), [OMIM:214950](http://purl.obolibrary.org/obo/OMIM_214950), [OMIM:614307](http://purl.obolibrary.org/obo/OMIM_614307), [Orphanet:79301](http://www.orpha.net/ORDO/Orphanet_79301), [Orphanet:79302](http://www.orpha.net/ORDO/Orphanet_79302), 

**Class expressions from DL-Learner:**

- [HP:0002910](http://purl.obolibrary.org/obo/HP_0002910) (Elevated hepatic transaminases) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 66.67%
- [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) and [HP:0002910](http://purl.obolibrary.org/obo/HP_0002910) (Elevated hepatic transaminases) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 66.67%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002910](http://purl.obolibrary.org/obo/HP_0002910) (Elevated hepatic transaminases) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 66.67%
- [HP:0001080](http://purl.obolibrary.org/obo/HP_0001080) (Biliary tract abnormality) and [HP:0002910](http://purl.obolibrary.org/obo/HP_0002910) (Elevated hepatic transaminases) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 66.67%
- [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 59.97%
- [HP:0002910](http://purl.obolibrary.org/obo/HP_0002910) (Elevated hepatic transaminases) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 59.97%
- [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 59.97%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 59.97%
- [HP:0001080](http://purl.obolibrary.org/obo/HP_0001080) (Biliary tract abnormality) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) 59.97%
- [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) and [HP:0100763](http://purl.obolibrary.org/obo/HP_0100763) (Abnormality of the lymphatic system) 59.97%
- [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) and [HP:0025408](http://purl.obolibrary.org/obo/HP_0025408) (Abnormal spleen morphology) 59.97%
- [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) and [HP:0011354](http://purl.obolibrary.org/obo/HP_0011354) (Generalized abnormality of skin) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 59.97%
- [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) and [HP:0011121](http://purl.obolibrary.org/obo/HP_0011121) (Abnormality of skin morphology) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 59.97%
- [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 59.97%
- [HP:0003271](http://purl.obolibrary.org/obo/HP_0003271) (Visceromegaly) and [HP:0006566](http://purl.obolibrary.org/obo/HP_0006566) (Neonatal cholestatic liver disease) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 59.97%


